Ultrasound Monitoring of Fetuses With Vascular Intra-uterine Growth Restriction (IUGR) Using the Isthmus Systolic Index (ISI): Feasibility, Comparison to Normal Fetuses and Association With Perinatal Mortality

NCT ID: NCT02813525

Last Updated: 2016-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

320 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-30

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fetuses with IUGR, there is a correlation between Doppler indices of cardiovascular function and perinatal mortality. An index of systolic flow velocities at the aortic isthmus (ISI) has previously been described in a population of normal fetuses. Fetuses with IUGR, the velocities recorded in the aortic isthmus could be affected and the normal development of the ISI should be changed, because of the increase in placental resistance on one hand, and the gradual deterioration ventricular functions on the other one. Investigators hypothesize that the ISI index in the context of placental insufficiency could provide additional arguments on the extraction timing, the prognosis and the fetal extraction mode to severe hypoxia. The primary outcome of the study is to evaluate in an exploratory manner the feasibility and the potential interest of longitudinal monitoring of fetuses with IUGR by Doppler systolic isthmus and the calculation of the ISI index.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Today evaluating the hemodynamic tolerance of the fetus with IUGR, is based on clinical evidence of fetal well-being and ultrasound arguments, since we know in fact that there is a correlation between Doppler indices of cardiovascular function and perinatal mortality.

The flow to the systolic aortic isthmus may be a marker of systolic performance balance of both ventricles. An index of systolic flow velocities (ISI) has previously been described in a population of normal fetuses. Fetuses with IUGR, the velocities recorded in the aortic isthmus could be affected and the normal development of the ISI should be changed, because of the increase in placental resistance on one hand, and the gradual deterioration ventricular functions on the other one. Investigators hypothesize that the ISI index in the context of placental insufficiency could provide additional arguments on the extraction timing, the prognosis and the fetal extraction mode to severe hypoxia.

The strategy evaluates the feasibility of measuring the ISI index on Doppler systolic flow in the aortic isthmus in the follow-up by ultrasound of the fetus with IUGR due to placental insufficiency.

The ISI is obtained from this flow by calculating the ratio of the minimum systolic velocity (called Nadir) on the peak systolic velocity (called Peak) or Nadir / Peak. The fetal extraction decision (birth) will be taken, blinded the outcome of the ISI, following the protocol of national recommendations for the management of fetuses with IUGR.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

IUGR

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IUGR group

estimated fetal weight \<10th percentile associated with an abnormal umbilical artery Doppler with IP\>95th percentile or a confirmation of placental vascular disease by histological examination

ISI index on Doppler systolic flow in the aortic isthmus

Intervention Type OTHER

Measure of the ISI index on Doppler systolic flow in the aortic isthmus in the follow-up by ultrasound of the fetus

CONTROL group

non IUGR fetuses for gestational age (normal for weight, Doppler, and structural analyse)

ISI index on Doppler systolic flow in the aortic isthmus

Intervention Type OTHER

Measure of the ISI index on Doppler systolic flow in the aortic isthmus in the follow-up by ultrasound of the fetus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ISI index on Doppler systolic flow in the aortic isthmus

Measure of the ISI index on Doppler systolic flow in the aortic isthmus in the follow-up by ultrasound of the fetus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age determined by ultrasound dating of the first quarter
* IUGR group: estimated fetal weight \<10th percentile associated with

* An abnormal umbilical artery Doppler with pulsatility index \>95th percentile
* OR a confirmation of placental vascular disease by histological examination
* CONTROL group: non IUGR fetuses for gestational age (normal for weight, Doppler, and structural analyse)

Exclusion Criteria

* Twin or multiple pregnancy,
* Fetal weight\> 10th percentile
* Presence of fetal infection
* Structural fetal anomaly or fetal chromosomal abnormality
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul PEREZ, MD

Role: STUDY_CHAIR

University Hospital Bordeaux, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de gynécologie-obstétrique et de médecine fœtale

Bordeaux, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Julie THOMAS, MD

Role: CONTACT

(0)557656109 ext. +33

Lorena SANCHEZ BLANCO

Role: CONTACT

(0)557656110 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Julie THOMAS, MD

Role: primary

(0)5 57 65 61 09 ext. +33

Lorena SANCHEZ BLANCO

Role: backup

(0)557656110 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2014/16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Ultrafast Ultrasound Imaging
NCT07299721 NOT_YET_RECRUITING